Clearside Biomedical

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. 

CEO
George M. Lasezkay
CEOGeorge M. Lasezkay
Employees
34
Employees34
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2011
Founded2011
Employees
34
Employees34

CLSD Key Statistics

Market cap
63.20M
Market cap63.20M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
136.57K
Average volume136.57K
High today
$1.11
High today$1.11
Low today
$1.05
Low today$1.05
Open price
$1.08
Open price$1.08
Volume
32.36K
Volume32.36K
52 Week high
$6.25
52 Week high$6.25
52 Week low
$1.03
52 Week low$1.03

CLSD Earnings

-$0.14
$0.01
$0.16
$0.31
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, Pre-Market
ActualExpected Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.